NATO Taps Palantir’s AI-Powered Maven System in Landmark Defense Deal
Strategic software acquisition underscores Europe's reliance on U.S. military tech amid Palantir stock rebound Palantir Technologies (PLTR) has secured a...
Luca is a proficient stock market reporter with a passion for dissecting complex market dynamics and uncovering transformative industry developments. With years of experience in leading editorial teams and overseeing coverage of the stock market and publicly traded companies, Luca has honed the ability to translate finance jargon into easily digestible articles. For tips and inquiries, reach out to Luca at tips@stoxpo.com.
Strategic software acquisition underscores Europe's reliance on U.S. military tech amid Palantir stock rebound Palantir Technologies (PLTR) has secured a...
Higher vehicle costs and softening demand prompt nearly 1 million-unit cut for 2025 outlook Goldman Sachs (GS) has sharply reduced...
CEO cites global tariff tensions as reason for murky outlook; company trims growth plans and braces for slower year Delta...
White House revisits $14.1 billion acquisition previously blocked over national security concerns Shares of U.S. Steel (NYSE: X) surged more...
Vietnam Offers to Slash Tariffs to Avoid U.S. Levies, Boosting Apparel and Retail Stocks Shares of major apparel and footwear...
Retail Giants Expected to Benefit as Shoppers Prioritize Essentials Retail giants Walmart (WMT) and Costco (COST) are well-positioned to navigate...
Elon Musk’s Political Ties, Factory Shutdowns, and Rising Competition Weigh on Performance Tesla’s vehicle deliveries declined in the first quarter...
XPeng Leads Growth, While NIO and Li Auto Maintain Steady Gains China’s top three smart electric vehicle (EV) manufacturers—NIO Inc....
Successful Solid-State Circuit Breaker Prototypes Signal Growth Potential Ideal Power (IPWR) has reached a key milestone in its commercialization strategy,...
Wall Street Reacts to Leadership Uncertainty in Biopharma Approvals The resignation of Peter Marks, director of the FDA’s Center for...
© 2024 All Rights Reserved: STOXPO.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information
Do you really wish to opt-out?